Nav: Home

Herbert A. Fleisch ESCEO-IOF Medal 2016 awarded to Professor René Rizzoli

April 14, 2016

Malaga, Spain, April 14, 2016 - Professor René Rizzoli, Emeritus Professor of Medicine at University Hospitals of Geneva has been awarded the prestigious Herbert A. Fleisch ESCEO-IOF Medal during the opening ceremony of the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

The Herbert A. Fleisch ESCEO-IOF Medal, awarded for the first time in 2010, recognizes a researcher who has made outstanding and groundbreaking achievements in basic bone science. The Award is named after the late Professor Herbert Fleisch, a renowned researcher whose groundbreaking work contributed to the development of the field of scientific knowledge about metabolic bone diseases and their treatment.

Professor Jean-Yves Reginster, ESCEO President and Co-Chair of WCO-IOF-ESCEO 2016 stated, "This award, named in honour of a pioneer in osteoporosis research, appropriately recognizes an individual whose work has considerably influenced knowledge about bone and mineral metabolism. I have had the privilege of collaborating with René Rizzoli for nearly two decades. Over this period, he has contributed significantly to the general management of osteoporosis and continues to do so."

René Rizzoli is Emeritus Professor of Medicine at University Hospitals of Geneva and former Head of the Service of Bone Diseases at the Geneva University Hospitals and Faculty of Medicine. He is presently a member of the International Osteoporosis Foundation (IOF) Executive Committee as treasurer, and also chairs the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Professor Rizzoli was involved in both basic and clinical research projects investigating hormone action, bone growth, the role of nutrition, calcium, bisphosphonates, selective oestrogen modulators, denosumab and strontium ranelate in the prevention and treatment of osteoporosis and disorders of mineral metabolism. He is the author of more than 800 publications. He is co-editor in chief of 'Calcified Tissue International and Musculoskeletal Research' and associate editor of 'Osteoporosis International'.
-end-
About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) :

Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17, 2016. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF :

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

About ESCEO :

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org

International Osteoporosis Foundation

Related Osteoporosis Articles:

Mind the (osteoporosis treatment) gap!
A new review, referencing key clinical studies, guidelines and audits, outlines the main global challenges (and their solutions) facing healthcare professionals and policymakers responsible for providing care to populations in relation to bone health and fracture prevention.
Outwitting the 'silent thief' of osteoporosis
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis.
Osteoporosis: Antibody crystallized
Inhibiting a protein called Sclerostin could probably help treating the bone-loss disease osteoporosis.
JBMR perspective: A crisis in the treatment of osteoporosis
The remarkable progress made over the past 30 years to reduce fractures and dramatically improve the quality of life for millions of osteoporosis patients is rapidly being reversed, say two bone health experts in a Journal of Bone and Mineral Research article published online today.
The developmental origins of osteoporosis
Osteoporosis may have its origins in early life, but the consequences are not apparent until late adult life.
Task force provides guidance on use of osteoporosis drugs
A new report by a task force of the American Society for Bone and Mineral Research provides guidance on the use of bisphosphonates, which are the most commonly used medications for osteoporosis.
Whole genome-sequencing uncovers new genetic cause for osteoporosis
Using one of the world's most extensive genetics data sets, an international research team led by Dr.
Men far less likely to prevent, screen for osteoporosis
While the consequences of osteoporosis are worse in men than women -- including death -- older males are far less likely to take preventive measures against the potentially devastating bone-thinning disease or accept recommendations for screening, according to startling new research by North Shore-LIJ Health System geriatricians.
'Aquatic osteoporosis' jellifying lakes
North American lakes are suffering from declining calcium levels, says new research from Queen's University.
Osteoporosis, not just a woman's disease
While osteoporosis prevention and treatment efforts have historically been focused on post-menopausal women, a new study from Beth Israel Deaconess Medical Center suggests that critical opportunities are being lost by not focusing more attention on bone loss and fracture risk in older men.

Related Osteoporosis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#532 A Class Conversation
This week we take a look at the sociology of class. What factors create and impact class? How do we try and study it? How does class play out differently in different countries like the US and the UK? How does it impact the political system? We talk with Daniel Laurison, Assistant Professor of Sociology at Swarthmore College and coauthor of the book "The Class Ceiling: Why it Pays to be Privileged", about class and its impacts on people and our systems.